ME MPJE study materials
ME MPJE study resources

Pharmacist-Prescribed Contraception With Migraine With Aura

ME MPJE · Put your knowledge to work in context.

All case studies

Pharmacist-Prescribed Contraception With Migraine With Aura

A 22-year-old woman comes to a pharmacy in Augusta, Maine, and asks for birth control pills without a prescription. She has no regular clinician and says she cannot take time off work for an appointment. The pharmacist has completed the required training and uses the state-approved self-screening tool. The woman's blood pressure is 138/88 mm Hg, her BMI is 31, and she reports migraines with aura that began two years ago. She takes no other medications, smokes one pack of cigarettes daily, and has no history of blood clots. She wants a 12-month supply of a combined estrogen-progestin pill. The pharmacy's protocol lists migraine with aura and smoking over age 35 as contraindications but does not address BMI.

1. Does Maine law authorize the pharmacist to prescribe and dispense a combined hormonal contraceptive in this situation? Identify the conditions and limits.

Read the worked answer

Maine authorizes pharmacists who have completed the required training to prescribe and dispense hormonal contraceptives under a board-approved protocol, using a self-screening tool. The authority is not unlimited: the pharmacist must screen for contraindications, measure blood pressure when required, counsel, and refer when findings fall outside the protocol.

Here the migraine with aura is the key finding. Estrogen-containing combined oral contraceptives are contraindicated in women with migraine with aura because of increased ischemic stroke risk. The pharmacist therefore should not prescribe the requested combined estrogen-progestin pill, even though the patient is 22 and otherwise may be eligible. The BMI of 31 and daily smoking are additional risk factors, but the migraine with aura alone is enough to stop the combined product. The pharmacist may discuss progestin-only options only if the protocol covers them and the pharmacist can safely determine eligibility; otherwise refer.

2. What should the pharmacist do with the abnormal findings, and what documentation is required?

Read the worked answer

Do not dispense the combined pill. Explain the reason in plain language: the aura puts her at higher stroke risk with estrogen. Refer her to a clinician or clinic that can evaluate her and prescribe an appropriate method, and offer to help with the referral. Document the self-screening answers, blood pressure, BMI, smoking, the migraine-with-aura finding, the specific protocol contraindication, the decision not to prescribe, the referral, and the counseling. Keep the record as protected health information. If the patient declines referral, document that too. The pharmacist should not create or record a prescription that was never issued.

3. If the patient asks for a 12-month supply, how does that affect the decision?

Read the worked answer

A 12-month supply is permitted only after the pharmacist has determined eligibility under the protocol; it does not override a contraindication. Because the combined product is contraindicated, the request for 12 months does not change the decision. If she were otherwise eligible, the pharmacist would still need to follow the protocol's supply limit and any requirement for follow-up or blood-pressure checks. The pharmacist can explain that the supply length is secondary to safety and that a clinician may prescribe a progestin-only or non-hormonal method with a 12-month supply if appropriate.